Celestone Chronodose is a medicine containing the active ingredient(s) betamethasone acetate + betamethasone sodium phosphate. On this page you will find out more about Celestone Chronodose, including side effects, age restrictions, food interactions and whether the medicine is subsidised by the government on the pharmaceutical benefits scheme (PBS)
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional. healthdirect medicines information is not intended for use in an emergency. If you are suffering an acute illness, overdose, or emergency condition, call triple zero (000) and ask for an ambulance.
Reasonable care has been taken to provide accurate information at the time of creation. This information is not intended to substitute medical advice, diagnosis or treatment and should not be exclusively relied on to manage or diagnose a medical condition. Please refer to our terms and conditions.
Active ingredient in this medicine: betamethasone acetate + betamethasone sodium phosphate
Information for medicine and pack size:
Celestone Chronodose injection suspension, 5 x 1 mL ampoules
Consumer Medicine Information leaflet:
This leaflet may also be found inside the medicine package. It contains information on side effects, age restrictions and other useful data.
What this medicine is for
Celestone Chronodose is indicated in the treatment of both severe and moderate conditions in acute and chronic self-limiting diseases responsive to systemic corticosteroid therapy and is especially useful in patients for whom treatment with oral corticosteroid medication is not feasible. Representative conditions: Rheumatic Disorders: rheumatoid arthritis, acute and subacute bursitis, epicondylitis, acute non-specific tenosynovitis, myositis, fibrositis, tendonitis, psoriatic arthritis. Collagen Diseases: systemic lupus erythematosus, scleroderma, dermatomyositis. Allergic States: status asthmaticus, chronic bronchial asthma, seasonal or perennial allergic rhinitis, severe allergic bronchitis, contact dermatitis, atopic dermatitis, hypersensitivity reactions to drug and insect bites. Dermatologic Conditions: localised, hypertrophic infiltrated lesions of lichen planus, psoriatic plaques, granuloma annulare and lichen simplex chronicus(neurodermatitis). keloids, discoid lupus erythematosus, necrobiosis lipoidica diabeticorum, alopecia areata. Antepartum use in the prevention of respiratory distress syndrome in premature infants when it is deemed necessary to induce labour prior to the thirty-second week of gestation becomes inevitable because of obstetric complication. Celestone Chronodose injection should also be considered for prophylactic treatment if the foetus is known to have a low lecithin/sphingomyelin ratio (or decreased foam stability test on amniotic fluid).
Table of characteristics
|Visual appearance||Clear colourless liquid containing easily suspendable white particles with no visible agglom erates; free from foreign matter|
|Dosage Form||Injection, suspension|
|Route of administration||Intracavitary|
1 mL x 2 (sample): Prescription Only Medicine, or Prescription Animal Remedy
1 mL x 5: Prescription Only Medicine, or Prescription Animal Remedy
There is one type of pack available.
Pack type 1
|Storage temperature||No information available|
|Storage conditions||No information available|
We were unable to verify that this medicine is available on the PBS (Pharmaceutical Benefits Scheme). Please consult your pharmacist if you need further information
The PBS provides a list of government subsidised medicines available to be dispensed to patients. Further information can be found on the Pharmaceutical Benefits Scheme website.
Is this medication banned in sport?
Check if you can use your medicine whilst playing sport. Search the Australian Sports Anti-Doping Authority (ASADA) database that provides information about the prohibited status of specific medications and/or the active ingredient based on the current World Anti-Doping Agency (WADA) Prohibited List.